New England Research & Management, Inc. Elevance Health, Inc. Transaction History
New England Research & Management, Inc.
- $213 Million
- Q3 2024
A detailed history of New England Research & Management, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, New England Research & Management, Inc. holds 1,650 shares of ELV stock, worth $616,539. This represents 0.4% of its overall portfolio holdings.
Number of Shares
1,650
Previous 1,700
2.94%
Holding current value
$616,539
Previous $921,000
6.84%
% of portfolio
0.4%
Previous 0.44%
Shares
12 transactions
Others Institutions Holding ELV
# of Institutions
1,861Shares Held
197MCall Options Held
1.03MPut Options Held
1.24M-
Vanguard Group Inc Valley Forge, PA21.3MShares$7.98 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$7.74 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$3.99 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$3.79 Billion0.61% of portfolio
-
Geode Capital Management, LLC Boston, MA4.85MShares$1.81 Billion0.21% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $89.7B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....